Key Publications January 18, 2021

Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial.

Eur Heart J. 2020;41:2952-2961

Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N